ANIP ANI Pharmaceuticals
- 56.010
- -2.180-3.75%
- 56.630
- +0.620+1.11%
ANI Pharmaceuticals News
ANI Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Cook Meredith
ANI Pharmaceuticals | 8-K: Current report
ANI Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Cook Meredith
ANI Pharmaceuticals | 8-K: Current report
ANI Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Davis Krista
ANI Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Lalwani Nikhil
ANI Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Cook Meredith
ANI Pharmaceuticals | 8-K: Current report
ANI Pharmaceuticals | 8-K: Current report
ANI Pharmaceuticals | 8-K: Current report
ANI Pharmaceuticals | 10-Q: Q2 2024 Earnings Report
ANI Pharmaceuticals | 8-K: ANI Pharmaceuticals Reports Second Quarter 2024 Financial Results and Raises 2024 Guidance
ANI Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Shanmugam Muthusamy
ANI Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Cook Meredith
ANI Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
ANI Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Shanmugam Muthusamy
ANI Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
ANI Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
ANI Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
ANI Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Cook Meredith
Analysis
Price Target
No Data
No Data